sotorasib,Docetaxel
Amgen
['lumakras', 'sclc', 'solid tumor', 'nsclc', 'krazati', 'mirati', 'amgen']
amgen, mirati report kras inhibitor activity in brain metastases, tumor agnostic cohorts at asco. researchers presented data from a trial of lumakras given to nsclc patients with brain metastases and krazati given across solid tumors. 